Leukocyte TelomerE Dynamics, Gender, Menopause, Insulin Resistance and Survival
Leukocyte TelomerE Dynamics, Gender, Menopause, Insulin Resistance and Survival
批准号:
7577059
负责人:
ABRAHAM AVIV
金额:
$50.55万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-02-15 至 2014-01-31
关键词:
AdultAgeAgingAtherosclerosisBiological MarkersBiologyBirthCD4 Positive T LymphocytesCD8B1 geneCardiovascular DiseasesCellsCigarette SmokerComplex Genetic TraitCross-Sectional StudiesCytomegalovirusDementiaDevelopmentDiseaseElderlyElementsEndowmentEnvironmental Risk FactorEpidemiologyEpstein-Barr Virus InfectionsFatty acid glycerol estersGap JunctionsGenderGender RoleGeneticHumanIGFBP3 geneIndividualInflammationInsulin ResistanceInsulin-Like Growth Factor ILengthLeukocytesLifeLife ExpectancyLinkLongevityLongitudinal StudiesMeasurementMen&aposs RoleMenopausal StatusMenopauseMetabolicMetabolismModelingNewborn InfantNon obeseObesityOverweightOxidative StressPersonsPhenotypePostmenopausePremenopauseRecordsResearchResortReverse Transcriptase Polymerase Chain ReactionRiskRoleSignal TransductionSmokerSocioeconomic StatusSouthern BlottingTelomere ShorteningTestingTimeTwin Multiple BirthVariantWomanage relatedagedbaseboyscohortdesigngirlsindexinginsightlow socioeconomic statusmenmortalitynon-smokerpeerpublic health relevancesedentarysextelomeretrait
中文摘要
描述(申请人提供):白细胞端粒长度(LTL)是一种复杂的遗传性状。LTL会随着年龄的增长而磨损,并与一系列与衰老相关的疾病和环境条件有关,这些疾病和环境条件会缩短人类的寿命。此外,LTL还预测了老年人的死亡率。横断面研究证实,成年男性的LTL比女性短,心血管疾病患者的LTL比健康同龄人短。在吸烟、久坐、超重或社会经济地位较低的人中,LTL也相对较短。总而言之,这些观察表明,LTL是人类衰老的生物标记物。影响白细胞端粒动态的两个因素是LTL及其与年龄相关的磨损率。虽然有大量关于LTL的信息,但关于LTL磨损率和衰老相关疾病之间的联系却知之甚少。该项目将采用同性双胞胎的纵向模型来检验以下中心假设:(I)年龄相关的白细胞端粒磨损在男性中比女性快,在绝经后的女性中比绝经前的女性快;(Ii)在氧化应激/炎症增加的情况下,白细胞端粒磨损速度更快,这通常与胰岛素抵抗增加和循环IGF-1减少有关;(Iii)在老年人中,LTL而不是年龄相关的端粒磨损率是死亡率的预测因子。这一特征部分解释了女性比男性寿命更长的原因;(Iv)与年龄相关的白细胞端粒磨损是可遗传的。这些假说将在丹麦双胞胎的两个队列中进行验证:吉米纳卡尔研究和丹麦双胞胎老龄化纵向研究(LSADT)。该项目的具体目标如下:1)根据两次跨越10岁的成年双胞胎(基线检查年龄为18-63岁),利用Southern blotting和实时荧光聚合酶链式反应(Real-Time-PCR)测量方法检测白细胞端粒动力学,并探索性别和绝经在端粒磨损中的作用及其与肥胖、胰岛素抵抗、IGF-1和氧化应激/炎症指数的联系;2)根据两次跨越10岁的老年双胞胎(基线检查年龄至少73岁)的白细胞端粒测量,检测白细胞端粒动力学与死亡率/存活率之间的联系。我们还将探讨CMV和EBV感染在LTL动力学中的作用。在一组老年人中,我们将通过Flow FISH来评估CD8+和CD4+细胞中端粒信号的强度。这些发现将加深我们对人类端粒生物学及其与衰老和寿命之间的联系的理解。公共卫生相关性:在这项研究中,我们将检验白细胞端粒缩短率是否记录了成人发生胰岛素抵抗的风险,并预测了老年人的死亡率。我们还将检查是否男性端粒磨损的速度比女性快,绝经后的端粒磨损速度是否比绝经前的女性快。我们的发现将为人类寿命方面的性别差异(女性比男性长寿)以及胰岛素抵抗在人类寿命中的作用提供新的见解。
英文摘要
DESCRIPTION (provided by applicant): Leukocyte telomere length (LTL) is a complex genetic trait. LTL undergoes attrition with age and is associated with a host of aging related diseases and environmental conditions that diminish the human lifespan. Moreover, LTL forecasts mortality in the elderly. Cross-sectional studies have established that LTL is shorter in adult men than women and in individuals with cardiovascular diseases than in their healthy peers. LTL is also relatively short in individuals who are smokers, sedentary, overweight or of low socio-economic status. Collectively, such observations suggest that LTL is a biomarker of human aging. The two elements that contribute to leukocyte telomere dynamics are LTL and its age-dependent attrition rate. Whereas considerable information is available about LTL, little is known about the links between LTL attrition rate and aging related diseases. This project will resort to a longitudinal model in same-sex twin pairs to test the following central hypotheses: (i) Age-dependent leukocyte telomere attrition is faster in men than in women and in post-menopausal than pre- menopausal women; (ii) Leukocyte telomere attrition rate is faster under conditions of increased oxidative stress/inflammation, which are often associated with increased insulin resistance and diminished circulating IGF-1; (iii) In the elderly, LTL but not age-dependent telomere attrition rate is a predictor of mortality. This feature explains in part the longer lifespan of women than men; (iv) Age-dependent leukocyte telomere attrition is heritable. These hypotheses will be tested in two cohorts of Danish twins: the Geminakar Study and the Longitudinal Study of Aging Danish Twins (LSADT). The following are the project's specific aims: 1) Examine leukocyte telomere dynamics by Southern blots and real time-PCR measurements of telomeres, based on two occasions that span 10 years in adult twins (aged 18-63 at the baseline examination) and explore the roles of gender and menopause in telomere attrition and their links with obesity, insulin resistance, IGF-1 and indices of oxidative stress/inflammation; 2) Examine the links between leukocyte telomere dynamics and mortality/survival, based on leukocyte telomere measurements on two occasions, spanning 10 years, in elderly twins (at least 73 years old at the baseline examination). We will also explore the role of CMV and EBV infections in LTL dynamics. In a subset of the elderly, we will evaluate by flow FISH telomere signal intensities in CD8+ and CD4+ cells. Findings will refine our understanding of human telomere biology and its connections with aging and lifespan. PUBLIC HEALTH RELEVANCE: In this study we will examine whether the rate of telomere shortening in leukocytes records the risk for the development of insulin resistance in adults and forecasts mortality in the elderly. We will also examine whether the rate of telomere attrition is faster in men than in women and in post-menopausal than pre-menopausal women. Our findings will provide a new insight into the gender gap in human longevity (women live longer than men) and the role of insulin resistance in the human lifespan.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Telomere Length Measurements: Strengths and Limitations
-
批准号:10025561
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2019
-
负责人:ABRAHAM AVIV
-
依托单位:
Telomere Length Measurements: Strengths and Limitations
-
批准号:10171754
-
项目类别:
-
资助金额:$11.77万
-
财政年份:2019
-
负责人:ABRAHAM AVIV
-
依托单位:
Leukocyte Telomere Length and Cardiovascular Disease in Jackson Heart Study
-
批准号:8703769
-
项目类别:
-
资助金额:$77.34万
-
财政年份:2013
-
负责人:ABRAHAM AVIV
-
依托单位:
Leukocyte Telomere Length and Cardiovascular Disease in Jackson Heart Study
-
批准号:8575407
-
项目类别:
-
资助金额:$80.51万
-
财政年份:2013
-
负责人:ABRAHAM AVIV
-
依托单位:
Determinants of Leukocyte Telomere Length at Birth
-
批准号:9022327
-
项目类别:
-
资助金额:$64.7万
-
财政年份:2012
-
负责人:ABRAHAM AVIV
-
依托单位:
Determinants of Leukocyte Telomere Length at Birth
-
批准号:8304771
-
项目类别:
-
资助金额:$68.62万
-
财政年份:2012
-
负责人:ABRAHAM AVIV
-
依托单位:
Determinants of Leukocyte Telomere Length at Birth
-
批准号:8632834
-
项目类别:
-
资助金额:$64.43万
-
财政年份:2012
-
负责人:ABRAHAM AVIV
-
依托单位:
Determinants of Leukocyte Telomere Length at Birth
-
批准号:8446991
-
项目类别:
-
资助金额:$63.28万
-
财政年份:2012
-
负责人:ABRAHAM AVIV
-
依托单位:
Leukocyte TelomerE Dynamics, Gender, Menopause, Insulin Resistance and Survival
-
批准号:8049613
-
项目类别:
-
资助金额:$47.06万
-
财政年份:2009
-
负责人:ABRAHAM AVIV
-
依托单位:
Leukocyte TelomerE Dynamics, Gender, Menopause, Insulin Resistance and Survival
-
批准号:8714260
-
项目类别:
-
资助金额:$5.87万
-
财政年份:2009
-
负责人:ABRAHAM AVIV
-
依托单位:
Leukocyte TelomerE Dynamics, Gender, Menopause, Insulin Resistance and Survival
-
批准号:8417671
-
项目类别:
-
资助金额:$27.7万
-
财政年份:2009
-
负责人:ABRAHAM AVIV
-
依托单位:
Leukocyte TelomerE Dynamics, Gender, Menopause, Insulin Resistance and Survival
-
批准号:7766948
-
项目类别:
-
资助金额:$47.91万
-
财政年份:2009
-
负责人:ABRAHAM AVIV
-
依托单位:
Leukocyte TelomerE Dynamics, Gender, Menopause, Insulin Resistance and Survival
-
批准号:8217224
-
项目类别:
-
资助金额:$39.48万
-
财政年份:2009
-
负责人:ABRAHAM AVIV
-
依托单位:
Human Telomere Genetics
-
批准号:7092122
-
项目类别:
-
资助金额:$37.05万
-
财政年份:2005
-
负责人:ABRAHAM AVIV
-
依托单位:
Human Telomere Genetics
-
批准号:7260444
-
项目类别:
-
资助金额:$38.45万
-
财政年份:2005
-
负责人:ABRAHAM AVIV
-
依托单位:
Human Telomere Genetics
-
批准号:7459780
-
项目类别:
-
资助金额:$38.3万
-
财政年份:2005
-
负责人:ABRAHAM AVIV
-
依托单位:
Human Telomere Genetics
-
批准号:6614247
-
项目类别:
-
资助金额:$40.26万
-
财政年份:2005
-
负责人:ABRAHAM AVIV
-
依托单位:
Genetics of the Sodium-Lithium Countertransport
-
批准号:6881158
-
项目类别:
-
资助金额:$57.81万
-
财政年份:2004
-
负责人:ABRAHAM AVIV
-
依托单位:
Genetics of the Sodium-Lithium Countertransport
-
批准号:6951742
-
项目类别:
-
资助金额:$1.2万
-
财政年份:2004
-
负责人:ABRAHAM AVIV
-
依托单位:
Genetics of the Sodium-Lithium Countertransport
-
批准号:6772031
-
项目类别:
-
资助金额:$62.23万
-
财政年份:2004
-
负责人:ABRAHAM AVIV
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: